Molecular Imaging: Page 119

PET links lower sleep levels with Alzheimer's risk

By Brian Casey

Individuals with mild cognitive impairment who slept less than six hours per night had higher levels of amyloid buildup -- a known contributor to Alzheimer's disease -- on PET scans than those who got more sleep, according to a study out of Japan published online June 9 in JAMA Open.

June 9, 2020

New tau PET tracer better targets source of Alzheimer's

By Wayne Forrest

A new PET tracer designed to improve the detection of tau deposits in key brain regions of patients suspected of Alzheimer's disease could greatly advance accurate diagnoses, according to a proof-of-concept study published in the June issue of the Journal of Nuclear Medicine.

June 9, 2020

IAEA expands SAFRON to support radionuclide therapy

By AuntMinnie.com staff writers

The International Atomic Energy Association (IAEA) has expanded its Safety in Radiation Oncology (SAFRON) radiotherapy patient safety tool to support radionuclide therapy.

June 8, 2020

Curium files for approvals of germanium-68 tracer

By AuntMinnie.com staff writers

Nuclear medicine firm Curium has filed regulatory applications in the U.S. and Europe for germanium-68, a radiopharmaceutical used in PET imaging.

June 8, 2020

AuntMinnie.com Molecular Imaging Insider

By Brian Casey

June 7, 2020

WMIS switches annual meeting to virtual conference

By AuntMinnie.com staff writers

The World Molecular Imaging Society (WMIS) said that its World Molecular Imaging Congress (WMIC) scheduled for October 7-10 will now be a fully virtual event in order to protect the health and well-being of attendees, staff, and the public.

June 3, 2020

What's the best way to image COVID-19?

By Kate Madden Yee

Researchers from Mount Sinai Hospital in New York City have released an overview of imaging modalities used to diagnose and manage COVID-19 pneumonia, trends to watch in artificial intelligence, and a description of nonchest complications from the disease. The review was published June 1 in Radiology: Cardiothoracic Imaging.

June 2, 2020

PET/MRI shows inflammation link to mitral valve prolapse

By Rebekah Moan

Researchers using a hybrid PET/MRI scanner detected a link between degenerative mitral valve prolapse and F-18 FDG uptake, a surrogate for myocardial inflammation and/or ischemia. The results, published online May 27 in JAMA Cardiology, apply to asymptomatic patients as well, suggesting an ongoing subclinical disease process.

May 31, 2020

FDA approves Avid's flortaucipir PET agent for tau imaging

By Brian Casey

In what the agency called a regulatory first, the U.S. Food and Drug Administration (FDA) has approved the radiopharmaceutical flortaucipir F-18 for imaging tau pathology on PET scans. The agent was developed by Eli Lilly subsidiary Avid Radiopharmaceuticals and will be marketed as Tauvid.

May 27, 2020

ITM changes name of isotope subsidiary

By AuntMinnie.com staff writers

German radiopharmaceutical group ITM Isotopen Technologien München has changed the name of its isotope technologies subsidiary from ITG Isotope Technologies Garching to ITM Medical Isotopes.

May 27, 2020

Imaging agent for breast cancer PET gets FDA nod

By AuntMinnie.com staff writers

Siemens Healthineers subsidiary PETNet Solutions and Zionexa have announced that the U.S. Food and Drug Administration (FDA) has approved Cerianna as a radiopharmaceutical for PET scans for recurrent or metastatic breast cancer.

May 26, 2020

International Isotopes' Q1 revenue declines

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes posted lower revenues in the first quarter of 2020 -- primarily due to the impact of the COVID-19 pandemic on nuclear medicine sales and the firm's decision to discontinue field services work within the radiological services segment.

May 21, 2020

Previous Page

Page 119 of 614

Next Page